Piramal Buys Selected Pfizer OTCs To Pursue Market Leader Goal
This article was originally published in PharmAsia News
Executive Summary
The consumer goods arm of Piramal Enterprises has just made its third acquisition in six months, keeping up a hectic deal-making pace in its quest to be one of India’s leading OTC players.